BCL2A1 and neoplasm: Statistical analysis demonstrated significantly elevated SPP1+BCL2A1+ TAMs scores in tumor tissues (p < 0.0001) (Figure 1G), establishing this newly identified TAM subtype as an HCC-enriched immune subset.